S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

VNDA Vanda Pharmaceuticals Inc

4.77

0.01 (0.21%)

02 May 2024 - Closed

Delayed by 15 minutes

Confidential Treatment Order (ct Order)

This regulatory filing also includes additional resources:
filename1.pdf

Vanda Pharmaceuticals (NASDAQ:VNDA)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Vanda Pharmaceuticals Charts.

Vanda Pharmaceuticals (NASDAQ:VNDA)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Vanda Pharmaceuticals Charts.

Vanda Pharmaceuticals Inc. News

Vanda Pharmaceuticals to Announce First Quarter 2024 Financial Results on May 8, 2024
Wednesday 1 May 2024 (1 day ago) • PR Newswire (US)

Shareholder Capital Delivers Letter to Independent Members of the Board of Vanda Pharmaceuticals
Thursday 25 April 2024 (7 days ago) • GlobeNewswire Inc.

Vanda Pharmaceuticals Reacts to U.S. Supreme Court's Denial of its Petition in HETLIOZ® ANDA Litigation
Tuesday 23 April 2024 (1 week ago) • PR Newswire (US)

Vanda Pharmaceuticals Adopts Limited Duration Stockholder Rights Plan
Thursday 18 April 2024 (2 weeks ago) • PR Newswire (US)

Vanda Pharmaceuticals Confirms Rejection of Unsolicited Takeover Proposals from Future Pak
Wednesday 17 April 2024 (2 weeks ago) • PR Newswire (US)

Biotech Catches Major Premarket Bid Following FDA Approval
Thursday 4 April 2024 (4 weeks ago) • AllPennyStocks.com

Vanda Pharmaceuticals' Fanapt® (iloperidone) Receives U.S. FDA Approval for the Acute Treatment of Bipolar I Disorder
Wednesday 3 April 2024 (4 weeks ago) • PR Newswire (US)

Form 8-K - Current report
Friday 8 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 7 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 7 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 7 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 7 March 2024 (2 months ago) • Edgar (US Regulatory)

More Vanda Pharmaceuticals Inc. News Articles

Australia And New Zealan...

AUD vs US Dollar

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions